Research Peptide
TB-500 (Thymosin Beta-4)
TB-500 (Thymosin Beta-4) is a synthetic research peptide supplied for controlled laboratory studies. Researchers use this compound in structured research focused on peptide behavior and interaction patterns.
- Synthetic peptide used in laboratory research settings
- Supports studies focused on peptide signaling and interaction behavior
- Suitable for controlled and repeatable research workflows
Tesamorelin 10MG
Tesamorelin is a synthetic research peptide supplied for controlled laboratory studies. Researchers use this compound in structured research focused on peptide signaling and sequence behavior.
- Synthetic peptide designed for laboratory research applications
- Used in studies focused on peptide signaling and structure
- Suitable for controlled and repeatable research workflows
Tesofensine
Tesofensine is a research compound supplied for controlled laboratory studies. Researchers use this compound in structured research focused on signaling behavior and molecular interaction models.
- Small-molecule research compound for laboratory investigation
- Used in studies focused on signaling pathways and interaction behavior
- Suitable for controlled and repeatable research workflows
Thymosin Alpha-1 10mg
Thymosin Alpha-1 is a research peptide supplied for controlled laboratory investigation. Researchers use this compound to support structured studies that focus on pathway exploration and mechanism based research. Its stable preparation format helps maintain consistency across experimental workflows.
- Used in laboratory research focused on pathway and mechanism exploration
- Supplied in lyophilized form to support stability during storage and handling
- Suitable for controlled and repeatable research workflows
Ultra-RT Ultratrutide™
Ultra-RT Ultratrutide™ is an advanced experimental quad-agonist peptide developed for metabolic pathway research, combining GLP-1, GIP, Glucagon, and Ghrelin receptor activity into a single innovative research compound designed to explore body composition, energy utilization, and lean tissue signaling pathways.
- Advanced quad-agonist targeting four metabolic receptor pathways
- Combines GLP-1, GIP, Glucagon, and Ghrelin receptor activity
- Designed for body composition and metabolic pathway research
- Supports investigation of lean tissue signaling mechanisms
- Innovative next-generation research peptide architecture
